Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. Novel erythropoiesis stimulating protein (NESP) is a glycoprotein with a threefold longer terminal half-life than recombinant human erythropoietin (rHuEPO) in humans. The aim of this study was to determi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2001-08, Vol.60 (2), p.741-747
Hauptverfasser:	Locatelli, Francesco, Olivares, Jesús, Walker, Rowan, Wilkie, Martin, Jenkins, Barbara, Dewey, Claire, Gray, Stephen J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged and chronic renal insufficiency anemia Anemia - drug therapy Anemia - etiology Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Erythropoietin - administration & dosage Erythropoietin - adverse effects Erythropoietin - analogs & derivatives Female hemoglobin Hemoglobins Humans Kidney Failure, Chronic - complications Male Medical sciences Middle Aged novel erythropoiesis stimulating factor Pharmacology. Drug treatments recombinant human erythropoietin Recombinant Proteins red blood cell Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!